Muthumani K - Search Results

1

A novel mouse AAV6 hACE2 transduction model of wild-type SARS-CoV-2 infection studied using synDNA immunogens.

Gary EN, Warner BM, Parzych EM, Griffin BD, Zhu X, Tailor N, Tursi NJ, Chan M, Purwar M, Vendramelli R, Choi J, Frost KL, Reeder S, Liaw K, Tello E, Ali AR, Yun K, Pei Y, Thomas SP, Rghei AD, Guilleman MM, Muthumani K, Smith T, Wootton SK, Patel A, Weiner DB, Kobasa D. Gary EN, et al. Among authors: muthumani k. iScience. 2021 Jul 23;24(7):102699. doi: 10.1016/j.isci.2021.102699. Epub 2021 Jun 8. iScience. 2021. PMID: 34124612 Free PMC article.

2

Immunogenicity of a novel DNA vaccine cassette expressing multiple human immunodeficiency virus (HIV-1) accessory genes.

Ayyavoo V, Kudchodkar S, Ramanathan MP, Le P, Muthumani K, Megalai NM, Dentchev T, Santiago-Barrios L, Mrinalini C, Weiner DB. Ayyavoo V, et al. Among authors: muthumani k. AIDS. 2000 Jan 7;14(1):1-9. doi: 10.1097/00002030-200001070-00001. AIDS. 2000. PMID: 10714562

3

Vpr-GFP virion particle identifies HIV-infected targets and preserves HIV-1Vpr function in macrophages and T-cells.

Muthumani K, Montaner LJ, Ayyavoo V, Weiner DB. Muthumani K, et al. DNA Cell Biol. 2000 Mar;19(3):179-88. doi: 10.1089/104454900314564. DNA Cell Biol. 2000. PMID: 10749170

4

HIV-1 Vpr regulates expression of beta chemokines in human primary lymphocytes and macrophages.

Muthumani K, Kudchodkar S, Papasavvas E, Montaner LJ, Weiner DB, Ayyavoo V. Muthumani K, et al. J Leukoc Biol. 2000 Sep;68(3):366-72. J Leukoc Biol. 2000. PMID: 10985253

5

Inclusion of Vpr accessory gene in a plasmid vaccine cocktail markedly reduces Nef vaccine effectiveness in vivo resulting in CD4 cell loss and increased viral loads in rhesus macaques.

Muthumani K, Bagarazzi M, Conway D, Hwang DS, Ayyavoo V, Zhang D, Manson K, Kim J, Boyer J, Weiner DB. Muthumani K, et al. J Med Primatol. 2002 Aug;31(4-5):179-85. doi: 10.1034/j.1600-0684.2002.02004.x. J Med Primatol. 2002. PMID: 12390540

6

Human immunodeficiency virus type 1 (HIV-1) Vpr-regulated cell death: insights into mechanism.

Muthumani K, Choo AY, Premkumar A, Hwang DS, Thieu KP, Desai BM, Weiner DB. Muthumani K, et al. Cell Death Differ. 2005 Aug;12 Suppl 1:962-70. doi: 10.1038/sj.cdd.4401583. Cell Death Differ. 2005. PMID: 15832179 Review.

7

Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination.

Fagone P, Shedlock DJ, Bao H, Kawalekar OU, Yan J, Gupta D, Morrow MP, Patel A, Kobinger GP, Muthumani K, Weiner DB. Fagone P, et al. Among authors: muthumani k. Gene Ther. 2011 Nov;18(11):1070-7. doi: 10.1038/gt.2011.59. Epub 2011 May 5. Gene Ther. 2011. PMID: 21544096 Free PMC article.

8

Optimized and enhanced DNA plasmid vector based in vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein Fab.

Muthumani K, Flingai S, Wise M, Tingey C, Ugen KE, Weiner DB. Muthumani K, et al. Hum Vaccin Immunother. 2013 Oct;9(10):2253-62. doi: 10.4161/hv.26498. Epub 2013 Sep 17. Hum Vaccin Immunother. 2013. PMID: 24045230 Free PMC article.

9

Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants.

Flingai S, Czerwonko M, Goodman J, Kudchodkar SB, Muthumani K, Weiner DB. Flingai S, et al. Among authors: muthumani k. Front Immunol. 2013 Nov 4;4:354. doi: 10.3389/fimmu.2013.00354. Front Immunol. 2013. PMID: 24204366 Free PMC article. Review.

10

Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy.

Flingai S, Plummer EM, Patel A, Shresta S, Mendoza JM, Broderick KE, Sardesai NY, Muthumani K, Weiner DB. Flingai S, et al. Among authors: muthumani k. Sci Rep. 2015 Jul 29;5:12616. doi: 10.1038/srep12616. Sci Rep. 2015. PMID: 26220099 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

130 results

Search Page